MTCH2 and colorectal carcinoma: Mechanistically, MTCH2 deficiency promotes the proteasome‐dependent ubiquitination of E2F4 and attenuates transcriptional inhibition of transferrin receptor (TFRC) by E2F4, ultimately facilitating TFRC‐mediated ferroptosis in CRC cells.